Stockholders’ Equity (Details) - Schedule of Compensation Expense Related to our Stock-Based Awards - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Schedule of Total Operating Expenses in the Consolidated Statements of Operations [Abstract] | ||
| Research and Development | $ 533 | $ 1,168 |
| General and Administrative | 1,288 | 1,181 |
| Cost of revenue | 62 | |
| Total | $ 1,883 | $ 2,349 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of selling, general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|